Getinge (OTCMKTS:GNGBY) Sees Large Volume Increase – Still a Buy?

Getinge (OTCMKTS:GNGBY) shares saw unusually-strong trading volume on Monday . Approximately 1,764 shares traded hands during trading, a decline of 17% from the previous session’s volume of 2,117 shares.The stock last traded at $23.89 and had previously closed at $24.3750.

Wall Street Analysts Forecast Growth

Separately, Nordea Equity Research raised shares of Getinge from a “hold” rating to a “buy” rating in a research report on Wednesday, October 22nd. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Getinge has a consensus rating of “Moderate Buy”.

Getinge Stock Up 0.1%

The business has a 50 day simple moving average of $22.92 and a 200-day simple moving average of $22.03. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.34 and a quick ratio of 0.80.

Getinge (OTCMKTS:GNGBY) last announced its quarterly earnings data on Tuesday, October 21st. The company reported $0.25 EPS for the quarter. Getinge had a net margin of 5.77% and a return on equity of 10.64%. The business had revenue of $864.74 million for the quarter.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.